These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2491954)

  • 1. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Cohen SM; Hasegawa R; Sakata T; Johansson SL
    Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.
    Sakata T; Hasegawa R; Johansson SL; Zenser TV; Cohen SM
    Cancer Res; 1986 Aug; 46(8):3903-6. PubMed ID: 3731063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dose on urinary bladder carcinogenesis induced in F344 rats by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Arai M; Cohen SM; Jacobs JB; Friedell GH
    J Natl Cancer Inst; 1979 Apr; 62(4):1013-6. PubMed ID: 285273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium phenobarbital and sodium saccharin in AIN-76A diet on carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and N,N-dibutylnitrosamine in male F344 rats.
    Imaida K; Wang CY
    Cancer Res; 1986 Dec; 46(12 Pt 1):6160-4. PubMed ID: 3779637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
    Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB
    Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis.
    Murasaki G; Zenser TV; Davis BB; Cohen SM
    Carcinogenesis; 1984 Jan; 5(1):53-5. PubMed ID: 6690086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bladder tumor promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats.
    Cohen SM; Ellwein LB; Okamura T; Masui T; Johansson SL; Smith RA; Wehner JM; Khachab M; Chappel CI; Schoenig GP
    Cancer Res; 1991 Apr; 51(7):1766-77. PubMed ID: 2004360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Fukushima S; Friedell GH; Jacobs JB; Cohen SM
    Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting effect of saccharin and DL-tryptophan in urinary bladder carcinogenesis.
    Cohen SM; Arai M; Jacobs JB; Friedell GH
    Cancer Res; 1979 Apr; 39(4):1207-17. PubMed ID: 421204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats.
    Johansson SL; Anderström C; von Schultz L; Larsson P
    Cancer Res; 1987 Jan; 47(2):559-62. PubMed ID: 3539325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrolein initiates rat urinary bladder carcinogenesis.
    Cohen SM; Garland EM; St John M; Okamura T; Smith RA
    Cancer Res; 1992 Jul; 52(13):3577-81. PubMed ID: 1617627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of L-tryptophan excess and vitamin B6 deficiency on rat urinary bladder cancer promotion.
    Birt DF; Julius AD; Hasegawa R; St John M; Cohen SM
    Cancer Res; 1987 Mar; 47(5):1244-50. PubMed ID: 3815336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of bladder tumor promoting activity in rats fed sodium saccharin in AIN-76A diet.
    Okamura T; Garland EM; Masui T; Sakata T; St John M; Cohen SM
    Cancer Res; 1991 Apr; 51(7):1778-82. PubMed ID: 2004361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neovascularization in rats during urinary bladder carcinogenesis induced by N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide.
    Cohen SM; Tatematsu M; Shinohara Y; Nakanishi K; Ito N
    J Natl Cancer Inst; 1980 Jul; 65(1):145-8. PubMed ID: 6930511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of single dose N-methyl-N-nitrosourea on bladder carcinogenesis by N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide in rats.
    Grossman HB; Sonda LP; Lesser ML
    Invest Urol; 1981 May; 18(8):457-9. PubMed ID: 7228579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term study of reversible and progressive urinary bladder cancer lesions in rats fed N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Jacobs JB; Arai M; Cohen SM; Friedell GH
    Cancer Res; 1977 Aug; 37(8 Pt 2):2817-21. PubMed ID: 872108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aspirin on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced epithelial proliferation in the urinary bladder and forestomach of the rat.
    Hasegawa R; St John M; Murasaki G; Fukushima S; Cohen SM
    Cancer Lett; 1984 Jan; 21(3):269-75. PubMed ID: 6692345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low susceptibility of analbuminemic rats to induction of bladder cancer by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Hosaka Y; Muramatsu M; Matsushima T; Niijima T; Nagase S
    Jpn J Cancer Res; 1985 Jul; 76(7):577-82. PubMed ID: 3928553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effects of cotinine and nicotine-N'-oxides on the development of tumors in rats initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    LaVoie EJ; Shigematsu A; Rivenson A; Mu B; Hoffmann D
    J Natl Cancer Inst; 1985 Dec; 75(6):1075-81. PubMed ID: 3865011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.